Summit Action
VC Fund
New York, United States
Summit Action is a VC fund in New York focused on E-Commerce and Health Care. Summit Action Fund is an investment firm affiliated with the Summit Series community
- Total investments:
- 22
- Last investment:
- Lead investor:
- 9%
- Fund size:
- $5.7M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Summit Action invests in
E-CommerceHealth CareMedicalHospitalApps
Stages Summit Action invests in
Series ASeedSeries BSeries CDebt Financing
Countries Summit Action invests in
United StatesUnited Kingdom
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brock Saunders
|
|||
Elliott Bisnow
|
|||
Investment Focus
Industry
- E-Commerce 7 (32%)
- Health Care 7 (32%)
- Medical 3 (14%)
- Hospital 3 (14%)
- Apps 2 (9%)
Stage
- Series A 5 (23%)
- Seed 4 (18%)
- Series B 4 (18%)
- Series C 4 (18%)
- Debt Financing 2 (9%)
Country
- United States 17 (77%)
- United Kingdom 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Brock Saunders
Managing Partner
|
Managing Partner | Total investments: 1 | Find email | |
|
Elliott Bisnow
Co-Managing Partner
|
Co-Managing Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ometria
|
Ometria’s mission is to build the brain that powers all communication between retailers and their customers. Ometria helps clients leverage data to build detailed customer profiles, and make sure that all messages they send are always relevant, leading to higher engagement and increased revenues.Ometria was founded by four serial entrepreneurs,with combined experience in e-commerce, computer science, mathematics, and SaaS, has been invested in by London’s most prominent entrepreneurs and investors, and is used by top retailers in the UK, Europe, and across the world. | $40M / Series C / Nov 11, 2021 | |
Moxe Health
|
Moxe Health streamlines the bi-directional exchange of clinical data between health plans and provider systems.The company provide solutions for risk adjustment, HEDIS and Star ratings, claims denial management, HCC reconciliation, patient summary, ADT notifications, and care gap management. Plans seamlessly send back data and insights whilenever straying from clinicians’ EHR workflows.Moxe’s clinical data clearinghouse allows health plans to easily receive information from health systems. Health plans can then seamlessly send back data and insights. With automated solutions for risk adjustment, quality, and care management programs, Moxe facilitates access to the information essential to your success in the market shift to value-based care.Moxe’s neutrality in providing data connectivity lets you realize the full potential of your existing investments in population health, quality, and analytics solutions. | Venture - Series Unknown / Jan 11, 2021 | |
|
Ometria
|
Ometria’s mission is to build the brain that powers all communication between retailers and their customers. Ometria helps clients leverage data to build detailed customer profiles, and make sure that all messages they send are always relevant, leading to higher engagement and increased revenues.Ometria was founded by four serial entrepreneurs,with combined experience in e-commerce, computer science, mathematics, and SaaS, has been invested in by London’s most prominent entrepreneurs and investors, and is used by top retailers in the UK, Europe, and across the world. | $21M / Series B / Sep 23, 2019 | |
Clyde
|
Clyde is a technology company transforming how retailers offer product protection and how customers take ownership of the products they love. Clyde’s platform enables retailers -- from startup to enterprise -- to offer product protection plans to customers. By offering protection with Clyde, retailers can increase revenue, reduce programmaintenance costs, and drive customer loyalty. | $3M / Seed / Nov 27, 2018 | |
Shield Bio
|
At Shield, we’re ensuring that antibiotic resistance doesn’t become more deadly than cancer.In 2050 more people will be dying of antibiotic resistant pathogens than cancer. Infections that were once treatable with a simple oral antibiotics are now requiring complex, painful treatments and resulting in serious health complications for patients.Gonorrhea is one such infection, having become resistant to over 10 different antibiotics, they have only one treatment that is still effective and resistance to this has already begun to emerge. With 820,000 new infections every year in the US, antibiotic resistance will spread quickly, which is why the CDC has resistant gonorrhea at an urgent threat level, the highest level available.Shield's novel genomic testing platform enables STI clinics to identify the antibiotic resistant strains of gonorrhea and other pathogens that their patients have, so they can select the correct antibiotics and halt the spread of antibiotic resistance. | $8M / Series A / May 23, 2018 | |
Koalafi
|
At Koalafi, we understand that some purchases just can't wait for "someday." That’s why we built the first nationwide platform that makes it possible for merchants to offer all of their customers, whether they have excellent or no credit, a wide range of pay-over-time plans through a single application.Founded in 2014, Koalafi isavailable at over 15,000 in store and online business across the country. With the help of Koalafi’s advanced technology and analytics, delightful experiences, and world-class support, thousands of merchants nationwide have grown their businesses, and more of their customers can finally dream bigger. Visit koalafi.com for more information. | $7M / Debt Financing / May 14, 2018 | |
|
Ometria
|
Ometria’s mission is to build the brain that powers all communication between retailers and their customers. Ometria helps clients leverage data to build detailed customer profiles, and make sure that all messages they send are always relevant, leading to higher engagement and increased revenues.Ometria was founded by four serial entrepreneurs,with combined experience in e-commerce, computer science, mathematics, and SaaS, has been invested in by London’s most prominent entrepreneurs and investors, and is used by top retailers in the UK, Europe, and across the world. | $6M / Series A / Oct 11, 2017 | |
myLaurel
|
myLaurel operates in the healthcare industry, providing in-home care, telemedicine, and extended follow-up services. The company's primary goal is to reduce the risk of hospitalizations and re-admissions for patients. myLaurel's unique utilization reduction and readmission prevention programs offer a comprehensive solution for patientpopulations. The company also offers acute care solutions in the home setting. myLaurel's services are backed by private equity and the company operates under private ownership. With Ready Responders, patients now have access to quality whole-person care in their homes, 16 hours a day, 365 days a year, and talented individuals are provided the opportunity to work with a rapidly growing, mission-driven company. They are in-network with most major insurance companies in the markets they serve. Ready Responders is backed by leading venture capital firms, including Google Ventures, Founders Fund, Rise of the Rest, and City Lights Capital. | $700K / Seed / Jul 21, 2017 | |
MakeSpace
|
MakeSpace aims to make storage convenient and consumer-friendly, creating a tech-enabled storage experience. Customers pay only for the space they need, and schedule pickups, drop-offs, and other services through an app and digital photo inventory. The company is now available in 31 markets across North America. | $30M / Series C / Apr 20, 2017 | |
Triplemint
|
Triplemint (formerly Suitey) is a software-powered real estate brokerage that is changing the way people buy, sell and rent homes. We believe that technology can vastly improve the consumer experience in real estate. Triplemint's platform combines powerful online property search tools with an offline real estate team to make the end-to-endreal estate experience more efficient. We are a VC-backed startup headquartered in New York City that is taking on a $60bn industry with a mission of shaping the future of real estate. | $4.5M / Series A / Feb 23, 2017 | |
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Health Care Investors
43,014 investors
Marketplace Investors
40,654 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
Health Care VC Funds
32,370 investors
Marketplace VC Funds
26,677 investors
Medical VC Funds
16,214 investors
SaaS Investors in United States
47,640 investors
FAQ
What does Summit Action invest in?
Summit Action invests primarily in E-Commerce, Health Care and Medical startups, most often at Series A and Seed stage. Most of the 22 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Summit Action?
Public channels for Summit Action include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Summit Action?
The team at Summit Action includes Brock Saunders (Managing Partner) and Elliott Bisnow (Co-Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
